Your account is not claimed yet. You can sign up with ORCID to claim your account.

Luca Quagliata

ResearcherID Loop profile Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 3

Top Topics

Circulating Tumor

Childhood Cancer

Top Venues

JCO oncology practice

Science advances

Diagnostics (Basel, Switzerland)

University Hospital Basel

Ruprecht Karls Universität Heidelberg Medizinische Fakultät Mannheim (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital Basel Apr 1o 2011 - Sep 30o 2018

Switzerland

Dr :: Molecular Pathology Unit

Education History

Ruprecht Karls Universität Heidelberg Medizinische Fakultät Mannheim

Germany

PHD :: CBTM

Publications

Jeffrey A Scott, Jochen K Lennerz, Melissa Lynne Johnson, Lucio N Gordan, Robert H Dumanois, Luca Quagliata, Lauren L Ritterhouse, Federico Cappuzzo, Brandon Wang, Mei Xue, Anupama Vasudevan, Prateesh Varughese, Varun Vaidya, Mike Gart, Natalie Dorrow, Hinco J Gierman, Rushir J Choksi
Compromised Outcomes in Stage IV Non-Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data. JCO oncology practice (2023)
Francesc Castro Giner, Sofia Gkountela, Cinzia Donato, Ilaria Alborelli, Luca Quagliata, Charlotte C K Ng, Salvatore Piscuoglio, Nicola Aceto
Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations. Diagnostics (Basel, Switzerland) 8 (2) (2018)
Don Benjamin, Marco Colombi, Sravanth K Hindupur, Charles Betz, Heidi A Lane, Mahmoud Y M El-Shemerly, Min Lu, Luca Quagliata, Luigi Terracciano, Suzette Moes, Timothy Sharpe, Aleksandra Wodnar-Filipowicz, Christoph Moroni, Michael N Hall
Syrosingopine sensitizes cancer cells to killing by metformin. Science advances 2 (12) (2016)